Neuraxis cash flow statement data for the quarter ended Mar 2026. This cash flow statement covers 16 quarters of results from Jun 2022 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Net Income | -0.70M | -1.30M | -1.14M | -1.06M | -1.31M | -3.12M | -1.65M | -1.86M | -2.78M | -1.72M | -1.47M | -2.30M | -1.73M | -2.13M | -1.75M | |
| Share-based CompensationStock Comp. | 0.00M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 1.32M | 0.16M | 0.40M | |||||
| Gains from Investment SecuritiesGains Investment | -0.06M | 0.09M | -1.27M | -0.23M | 0.04M | -0.59M | -0.05M | 0.01M | -0.01M | 0.01M | -0.01M | |||||
| Asset Writedowns and ImpairmentWritedown | 0.02M | 0.01M | -0.02M | -0.00M | 0.01M | 0.00M | 0.02M | 0.01M | 0.01M | 0.00M | -0.02M | 0.01M | 0.01M | |||
| Cash from OperationsCash from Ops. | -0.91M | -0.21M | -0.62M | -0.63M | -2.82M | -2.63M | -1.33M | -1.62M | -1.39M | -1.76M | -1.60M | -1.47M | -1.43M | -1.93M | ||
| Depreciation, Depletion & Amortization | ||||||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.01M | 0.02M | 0.07M | 2.66M | 0.89M | 1.33M | 0.02M | 0.06M | 0.04M | |||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.02M | 0.02M | ||
| Change in Working Capital | ||||||||||||||||
| Change in ReceivablesChange Receivables | 0.12M | -0.17M | 0.19M | -0.12M | -0.10M | -0.04M | 0.03M | 0.06M | -0.09M | 0.18M | -910.00 | -0.12M | -0.02M | 0.09M | ||
| Change in InventoryChange Inventory | 0.00M | -0.01M | 0.03M | -0.03M | -0.01M | -0.01M | -0.00M | 0.02M | -0.02M | 0.03M | -0.01M | 0.11M | -0.01M | 0.15M | ||
| Change in Account PayablesChange Payables | 0.48M | 0.75M | 0.47M | 0.38M | -1.87M | 0.64M | 0.03M | -0.12M | -0.16M | -0.37M | -0.06M | -0.07M | 0.42M | -0.75M | ||
| Change in Accured ExpensesChange Accured Exp. | -0.01M | 0.02M | 0.19M | 0.15M | -0.76M | 0.12M | 0.42M | 0.59M | -0.24M | 0.18M | 0.16M | 0.25M | 0.14M | 0.54M | ||
| Investing Activities | ||||||||||||||||
| Capital ExpendituresCapex | -0.01M | 0.01M | 0.00M | 0.00M | 0.02M | 0.01M | 0.01M | 0.00M | 0.02M | 0.01M | 0.01M | |||||
| Cash from Investing ActivitiesCash from Investing | 0.04M | -0.05M | -0.01M | -0.01M | -0.04M | -0.02M | -0.01M | -0.01M | -0.00M | -0.02M | -0.01M | -0.11M | ||||
| Financing Activities | ||||||||||||||||
| Other financing activitiesOther financing | 0.20M | -0.17M | 0.17M | 0.11M | 29.00 | 0.10M | ||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.81M | 0.51M | 0.42M | 0.64M | 3.57M | 1.96M | 1.35M | 3.31M | -0.11M | 5.19M | -0.07M | 5.46M | -0.18M | 2.63M | ||
| Change in Capital Stock | ||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | -0.62M | 2.73M | 2.31M | |||||||||||||
| Additional items | ||||||||||||||||
| Change in Cash | -0.07M | 0.25M | -0.21M | 0.01M | 0.71M | -0.68M | 0.00M | 1.68M | -1.50M | 3.44M | -1.69M | 3.98M | -1.61M | 0.59M | ||
| Free Cash FlowFCF | -0.91M | -0.20M | -0.63M | -0.63M | -2.82M | -2.65M | -1.35M | -1.62M | -1.40M | -1.76M | -1.62M | -1.47M | -1.43M | -1.94M | ||
| Net Cash FlowNCF | -0.07M | 0.25M | -0.21M | 0.01M | 0.71M | -0.68M | 0.00M | 1.68M | -1.50M | 3.44M | -1.69M | 3.98M | -1.61M | 0.59M |